Literature DB >> 14996933

Parkinson's disease alpha-synuclein mutations exhibit defective axonal transport in cultured neurons.

Anirban R Saha1, Josephine Hill, Michelle A Utton, Ayodeji A Asuni, Steven Ackerley, Andrew J Grierson, Christopher C Miller, Alun M Davies, Vladimir L Buchman, Brian H Anderton, Diane P Hanger.   

Abstract

Alpha-synuclein is a major protein constituent of Lewy bodies and mutations in alpha-synuclein cause familial autosomal dominant Parkinson's disease. One explanation for the formation of perikaryal and neuritic aggregates of alpha-synuclein, which is a presynaptic protein, is that the mutations disrupt alpha-synuclein transport and lead to its proximal accumulation. We found that mutant forms of alpha-synuclein, either associated with Parkinson's disease (A30P or A53T) or mimicking defined serine, but not tyrosine, phosphorylation states exhibit reduced axonal transport following transfection into cultured neurons. Furthermore, transfection of A30P, but not wild-type, alpha-synuclein results in accumulation of the protein proximal to the cell body. We propose that the reduced axonal transport exhibited by the Parkinson's disease-associated alpha-synuclein mutants examined in this study might contribute to perikaryal accumulation of alpha-synuclein and hence Lewy body formation and neuritic abnormalities in diseased brain.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14996933     DOI: 10.1242/jcs.00967

Source DB:  PubMed          Journal:  J Cell Sci        ISSN: 0021-9533            Impact factor:   5.285


  64 in total

1.  Autoproteolytic fragments are intermediates in the oligomerization/aggregation of the Parkinson's disease protein alpha-synuclein as revealed by ion mobility mass spectrometry.

Authors:  Camelia Vlad; Kathrin Lindner; Christiaan Karreman; Stefan Schildknecht; Marcel Leist; Nick Tomczyk; John Rontree; James Langridge; Karin Danzer; Thomas Ciossek; Alina Petre; Michael L Gross; Bastian Hengerer; Michael Przybylski
Journal:  Chembiochem       Date:  2011-11-07       Impact factor: 3.164

Review 2.  Retrograde axonal transport: pathways to cell death?

Authors:  Eran Perlson; Sandra Maday; Meng-Meng Fu; Armen J Moughamian; Erika L F Holzbaur
Journal:  Trends Neurosci       Date:  2010-04-29       Impact factor: 13.837

3.  Cytosolic carboxypeptidase 5 removes α- and γ-linked glutamates from tubulin.

Authors:  Iryna Berezniuk; Peter J Lyons; Juan J Sironi; Hui Xiao; Mitsutoshi Setou; Ruth H Angeletti; Koji Ikegami; Lloyd D Fricker
Journal:  J Biol Chem       Date:  2013-09-10       Impact factor: 5.157

4.  Cargo distributions differentiate pathological axonal transport impairments.

Authors:  Cassie S Mitchell; Robert H Lee
Journal:  J Theor Biol       Date:  2012-01-25       Impact factor: 2.691

5.  The parkinsonian mimetic, MPP+, specifically impairs mitochondrial transport in dopamine axons.

Authors:  Jeong Sook Kim-Han; Jo Ann Antenor-Dorsey; Karen L O'Malley
Journal:  J Neurosci       Date:  2011-05-11       Impact factor: 6.167

6.  Dynamic changes in presynaptic and axonal transport proteins combined with striatal neuroinflammation precede dopaminergic neuronal loss in a rat model of AAV alpha-synucleinopathy.

Authors:  Chee Yeun Chung; James B Koprich; Hasan Siddiqi; Ole Isacson
Journal:  J Neurosci       Date:  2009-03-18       Impact factor: 6.167

Review 7.  Alpha-synuclein and intracellular trafficking: impact on the spreading of Parkinson's disease pathology.

Authors:  Sibylle E Eisbach; Tiago F Outeiro
Journal:  J Mol Med (Berl)       Date:  2013-04-25       Impact factor: 4.599

8.  Phosphorylation at Ser-129 but not the phosphomimics S129E/D inhibits the fibrillation of alpha-synuclein.

Authors:  Katerina E Paleologou; Adrian W Schmid; Carla C Rospigliosi; Hai-Young Kim; Gonzalo R Lamberto; Ross A Fredenburg; Peter T Lansbury; Claudio O Fernandez; David Eliezer; Markus Zweckstetter; Hilal A Lashuel
Journal:  J Biol Chem       Date:  2008-03-14       Impact factor: 5.157

9.  Reduced axonal transport in Parkinson's disease cybrid neurites is restored by light therapy.

Authors:  Patricia A Trimmer; Kathleen M Schwartz; M Kathleen Borland; Luis De Taboada; Jackson Streeter; Uri Oron
Journal:  Mol Neurodegener       Date:  2009-06-17       Impact factor: 14.195

10.  Abberant alpha-synuclein confers toxicity to neurons in part through inhibition of chaperone-mediated autophagy.

Authors:  Maria Xilouri; Tereza Vogiatzi; Kostas Vekrellis; David Park; Leonidas Stefanis
Journal:  PLoS One       Date:  2009-05-13       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.